Ten departments including the Ministry of Industry and Information Technology issued the “Fifteenth Five-Year Plan for the Development of the Pharmaceutical Industry”. The plan proposes to accelerate the deployment of cutting-edge technology and products. Strengthen interdisciplinary integration and the supply of cutting-edge technology, and support joint research by pharmaceutical industry enterprises, universities, research institutes, medical institutions, etc. Accelerate drug research and development with new technologies such as artificial intelligence, quantum computing, supercomputing, and computational medicine, explore new models of pharmaceutical device production such as ultra-limited manufacturing, space pharmaceuticals, and biomantry manufacturing, deepen the application of cutting-edge technologies such as gene editing, precise molecular delivery, cell programming and regulation, advanced omics, and next-generation brain-computer interfaces, break through key technologies such as artificial life system synthesis, organoid and organ chips, general-purpose cell therapy, complex regenerative organs, and cultivate several new growth points.

Ten departments including the Ministry of Industry and Information Technology issued the “Fifteenth Five-Year Plan for the Development of the Pharmaceutical Industry”. The plan proposes to accelerate the deployment of cutting-edge technology and products. Strengthen interdisciplinary integration and the supply of cutting-edge technology, and support joint research by pharmaceutical industry enterprises, universities, research institutes, medical institutions, etc. Accelerate drug research and development with new technologies such as artificial intelligence, quantum computing, supercomputing, and computational medicine, explore new models of pharmaceutical device production such as ultra-limited manufacturing, space pharmaceuticals, and biomantry manufacturing, deepen the application of cutting-edge technologies such as gene editing, precise molecular delivery, cell programming and regulation, advanced omics, and next-generation brain-computer interfaces, break through key technologies such as artificial life system synthesis, organoid and organ chips, general-purpose cell therapy, complex regenerative organs, and cultivate several new growth points.